Compass Therapeutics, Inc.CMPXNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | -100.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | -100.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +7.98% | +7.02% | +1.19% | +0.50% | +0.50% |
| Weighted Average Shares Diluted Growth | +7.98% | +7.02% | +1.19% | +0.50% | +0.50% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -12.28% | -10.50% | -18.43% | -25.01% | +55.05% |
| Book Value per Share Growth | -19.91% | -21.22% | -30.61% | -36.52% | +50.70% |
| Debt Growth | +236.61% | +282.80% | +351.59% | +810.29% | +43.48% |
| R&D Expense Growth | -2.48% | +4.93% | +37.09% | +46.90% | +48.93% |
| SG&A Expenses Growth | +17.19% | +19.18% | +51.23% | -1.48% | -17.54% |